NeuroMetrix, Inc.
NURO
$4.36
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/23/2025
-
Ticker Report
4/15/2025
-
Ticker Report
3/31/2025
-
Accesswire
3/31/2025
-
Ticker Report
3/21/2025
-
Ticker Report
2/16/2025
-
Ticker Report
2/10/2025
-
Ticker Report
2/3/2025
-
Ticker Report
1/27/2025
-
Ticker Report
1/25/2025
-
Ticker Report
1/17/2025
-
Ticker Report
1/8/2025
-
Ticker Report
1/7/2025
-
PR Newswire
1/7/2025
-
GuruFocus
1/6/2025
-
Business Wire
1/6/2025
-
Insider Monkey
12/31/2024
-
Ticker Report
12/31/2024
-
Ticker Report
12/30/2024
-
TipRanks Financial Blog
12/30/2024
-
TipRanks Financial Blog
12/30/2024
-
The Fly
12/23/2024
-
PR Newswire
12/22/2024
-
Ticker Report
12/21/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 890 9989
Address
4B Gill Street
Woburn, MA 01801
Woburn, MA 01801
Country
Year Founded
Business Description
Sector
Industry
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to...
more